precocious puberty- age cut-off
before age 8 in girls
before age 9 in boys
does not always have to be treated if not serious or impactful
precocious puberty causes
familial/genetic (nonpathologic)
central (True) precosious puberty: early activation of hypothalamic pituitary- gonadal axis
pseudoprecocios puberty: autonomous excess secretion of sex steroids
congenital adrenal hyperplasia
-cortisol replacement
complications:
short stature
social and emotional adjustment issues
precocious puberty isosexual vs heterosexual
iso: premature sexual development appropriate for gender
10% due to CNS lesions/trauma
Complete- all sexual characteristics develop prematurely
incomplete- only 1 sexual characteristic develops prematurely
hetero: virilization of girls (exogenous androgens, androgen- secreting neoplasm, congenital adrenal hyperplasia)
feminization of boys
precocious puberty isosexual vs heterosexual
iso: premature sexual development appropriate for gender
10% due to CNS lesions/trauma
Complete- all sexual characteristics develop prematurely
incomplete- only 1 sexual characteristic develops prematurely
hetero: virilization of girls (exogenous androgens, androgen- secreting neoplasm, congenital adrenal hyperplasia)
feminization of boys
precocious puberty causes
familial/genetic (nonpathologic)
central (True) precosious puberty: early activation of hypothalamic pituitary- gonadal axis
pseudoprecocios puberty: autonomous excess secretion of sex steroids
precocious puberty isosexual vs heterosexual
iso: premature sexual development appropriate for gender
10% due to CNS lesions/trauma
Complete- all sexual characteristics develop prematurely
incomplete- only 1 sexual characteristic develops prematurely
hetero: virilization of girls (exogenous androgens, androgen- secreting neoplasm, congenital adrenal hyperplasia)
feminization of boys
pregesterone
pro-gestation stimulates endometrial development inhibits uterine contraction increases thickness of cervical mucus increases basal body temp inhibits LH and FSH secretion
decrease in progesterone level leads to menstruation (simulate this by giving progesterone and then stopping it)
bHCG
maintains corpus luteum and progesterone secretion
mean age of menarch in the US
13
pregesterone
pro-gestation
True precocious puberty
high LH and FSH
GnRH will increase FSH further
treat by inducing menopause with continuous GnRH analog
mean age of menarch in the US
13
Pseudoprecocios puberty
low LH and FSH
no response when GnRH given
True precocious puberty
high LH and FSH
GnRH will increase FSH further
how long is luteal phase
13-14 days
FSH triggers release of which hormone from follicle?
estradiol
Menopause
end of menstruation due to cessation of ovarian function
Average age: 51.5 years
Premature ovarian failure: amenorrhea for at least 1 year before age 40
Labs, which are not so necessary would show
increased FSH, LH,
decreased estrogen
Menopause is diagnosed with 12 months of amenorrhea in a woman over 45yo (diagnostic and requires no additional work-up)
A woman over age 45 with irregular menses (oligoamenorrhea) and menopausal symptoms (hot flashes, mood changes, sleep disturbances) can be assumed to be going through perimenopause
Serum FSH increases in the perimenopausal period and after menopause, but this is of little diagnostic value beyong obtaining a menstrual history and history of symptoms
If younger than 45, other etiologies for oligo/amenorrhea must be excluded (TSH, serum hCG, prolactin, FSH)
Premature ovarian failure:
amenorrhea for at least 1 year before age 40, or high FSH + menstrual irregularity before age 40
tobacco radiation chemo abdominal disorders pelvic surgery
Perimenopause
ovarian response to FSH and LH decreases
FSH and LH levels increase
Estrogen levels fluctuate
irregular bleeding, sometimes heavier flow
Endometrial biopsy to r/o other causes
Menopause symptoms
hot flashes breast pain sweating fatigue anxiety/depression dyspareunia urinary frequency and dysuria changes in bowel habits vaginal atrophy bladder symptoms stress urinary incontinence
Menopause treatment
Women’s Health Initiative- gave asx post- menopausal women estrogen and progesterone to see if it is cardioprotective, and they had more heart attacks and cardiac events so estrogen is now only used to treat symptoms
Topical estrogen is contraindicated in anyone with history of estrogen- sensitive or breast cancer
Dyspareunia can be treated with
Osteoporosis:
Hot flashes and mood swings:
-hormone replacement therapy at least for a little while
Pros and cons of hormone replacement therapy for menopause
Pro:
CONS
Non-hormonal options for treating hot flashes
Side effects of estrogen therapy
weight gain nausea breast tenderness headache endometrial proliferation